Sourcing quality markers Quality assessment for any research peptide vial reduces to three documents and one in-vial observation: HPLC purity certificate: reverse-phase HPLC chromatogram with a single dominant peak per component, integrated area reported, target at or above 99 percent
Higher cost diagnostic radiopharmaceuticals were one specific type of product that, prior to CY 2025, was policy packaged under the category described by 419.2(b)(15)
For a general overview of this product format and batch transparency, see our BPC-157 Canada research overview
By means of HPLC-ESI-QTOF-MS, the metabolic intermediates of DEHP are identified for SP4, which include mono-2-ethylhexylphthalate (MEHP), mono-butyl phthalate (MBP), phthalic acid (PA), salicylic acid (SA), and 4-oxo-hexanoic acid